CSat Investment Advisory, L.P. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 391 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
CSat Investment Advisory, L.P. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$23,000
-8.0%
486
+14.1%
0.00%
-33.3%
Q2 2020$25,000
-59.0%
426
-66.7%
0.00%
-76.9%
Q1 2020$61,000
-35.8%
1,280
-19.0%
0.01%
-48.0%
Q4 2019$95,000
-12.8%
1,580
-13.4%
0.02%
-26.5%
Q3 2019$109,000
+13.5%
1,824
+21.9%
0.03%0.0%
Q2 2019$96,0001,4960.03%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Bellevue Group AG 9,347,926$313,529,0003.18%
Sicart Associates LLC 291,254$9,769,0002.66%
Camber Capital Management LP 2,500,000$83,850,0002.58%
SECTOR GAMMA AS 263,870$8,850,0001.76%
Parkman Healthcare Partners LLC 136,380$4,574,0001.16%
Eversept Partners, LP 450,501$15,109,8041.05%
SPHERA FUNDS MANAGEMENT LTD. 350,000$11,739,0000.99%
TANAKA CAPITAL MANAGEMENT INC 16,661$559,0000.80%
Sonora Investment Management, LLC 163,703$5,491,0000.69%
ARK Investment Management 8,511,384$285,472,0000.69%
View complete list of IONIS PHARMACEUTICALS INC shareholders